Autoreactive T cells target neoself-antigens in lupus

Kyle Vogan
DOI: https://doi.org/10.1038/s41588-024-01955-9
IF: 30.8
2024-10-11
Nature Genetics
Abstract:Reduced expression of the invariant chain impairs antigen presentation by the major histocompatibility complex class II (MHC-II), triggering the production of autoantibodies against aberrant self-antigens, termed neoself-antigens. To further examine the impact of these processes in vivo, Mori et al. generated mice harboring an inducible knockout allele for the invariant chain. They found that ablation of the invariant chain in adult mice resulted in a lupus-like systemic phenotype, accompanied by presentation of neoself-antigens on MHC-II, activation of autoreactive B cells and T cells, and clonal expansion of neoself-reactive T cells. Next, they analyzed T cell receptor (TCR) repertoires from human patients with systemic lupus erythematosus (SLE) compared with healthy controls, and found that TCRs recognizing neoself-antigens were specifically present in patients with SLE, comprising roughly 10% of their TCR repertoire. Notably, they also found evidence that reactivation of Epstein–Barr virus (EBV), a known risk factor for SLE, resulted in decreased invariant chain expression and a corresponding increase in the presentation of neoself-antigens on MHC-II. Collectively, these results provide a plausible model linking EBV reactivation with aberrant production of neoself-antigens as an etiological trigger underlying the autoimmune processes that drive SLE. Original reference: Cell https://doi.org/10.1016/j.cell.2024.08.025 (2024)
genetics & heredity
What problem does this paper attempt to address?